ArticleJournal of cancer research and clinical oncology2023

Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer.

Green Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.